Global Saliva-based Screening Market Research Report 2026(Status and Outlook)
Saliva-based screening refers to a diagnostic or testing method that uses a person"s saliva (spit) as a sample to detect the presence of certain substances or conditions. This type of screening is commonly used in various fields, including healthcare, drug testing, and disease detection. Saliva-based screening offers several advantages, such as being non-invasive, easy to collect, and often more convenient than traditional blood or urine tests.During the COVID-19 pandemic, saliva-based tests gained significant attention and adoption as an alternative to nasal swab tests. This trend was expected to continue as researchers refined and expanded saliva-based testing methods. Advances in this area were anticipated to improve test accuracy, ease of collection, and scalability.
The global Saliva-based Screening market size was estimated at USD 396.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Saliva-based Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Saliva-based Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Saliva-based Screening market.
Global Saliva-based Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Thermo Fisher scientific
Qiagen
Hologic
Takara Bio Inc
Arcis Biotechnology Limited
GeneProof
Abacus ALS
Chai Inc.
Kolplast Group
Lucence Health INc
Vitagene
Therma Bright Inc
ACON Laboratories, Inc
TODA PHARMA
Norgen Biotek Corp.
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
KYODO INTERNATIONAL INC.
Canvax
Zymo Research Corporation.
Salimetrics
NEST Scientific USA
Miraclean Technology Co. Ltd
Mawi DNA Technologies
Cell Projects Ltd.
Market Segmentation (by Type)
Direct Sample to PCR
RT-qPCR
Lateral Flow Assays
Market Segmentation (by Application)
Diagnostic Laboratories
Hospitals & Clinics
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Saliva-based Screening Market
Overview of the regional outlook of the Saliva-based Screening Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Saliva-based Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Saliva-based Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Saliva-based Screening market size was estimated at USD 396.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Saliva-based Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Saliva-based Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Saliva-based Screening market.
Global Saliva-based Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Thermo Fisher scientific
Qiagen
Hologic
Takara Bio Inc
Arcis Biotechnology Limited
GeneProof
Abacus ALS
Chai Inc.
Kolplast Group
Lucence Health INc
Vitagene
Therma Bright Inc
ACON Laboratories, Inc
TODA PHARMA
Norgen Biotek Corp.
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
KYODO INTERNATIONAL INC.
Canvax
Zymo Research Corporation.
Salimetrics
NEST Scientific USA
Miraclean Technology Co. Ltd
Mawi DNA Technologies
Cell Projects Ltd.
Market Segmentation (by Type)
Direct Sample to PCR
RT-qPCR
Lateral Flow Assays
Market Segmentation (by Application)
Diagnostic Laboratories
Hospitals & Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Saliva-based Screening Market
Overview of the regional outlook of the Saliva-based Screening Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Saliva-based Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Saliva-based Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Saliva-based Screening
1.2 Key Market Segments
1.2.1 Saliva-based Screening Segment by Type
1.2.2 Saliva-based Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SALIVA-BASED SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Saliva-based Screening Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Saliva-based Screening Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SALIVA-BASED SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Saliva-based Screening Product Life Cycle
3.3 Global Saliva-based Screening Sales by Manufacturers (2020-2025)
3.4 Global Saliva-based Screening Revenue Market Share by Manufacturers (2020-2025)
3.5 Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Saliva-based Screening Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Saliva-based Screening Market Competitive Situation and Trends
3.8.1 Saliva-based Screening Market Concentration Rate
3.8.2 Global 5 and 10 Largest Saliva-based Screening Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SALIVA-BASED SCREENING INDUSTRY CHAIN ANALYSIS
4.1 Saliva-based Screening Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SALIVA-BASED SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Saliva-based Screening Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Saliva-based Screening Market
5.7 ESG Ratings of Leading Companies
6 SALIVA-BASED SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Saliva-based Screening Sales Market Share by Type (2020-2025)
6.3 Global Saliva-based Screening Market Size by Type (2020-2025)
6.4 Global Saliva-based Screening Price by Type (2020-2025)
7 SALIVA-BASED SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Saliva-based Screening Market Sales by Application (2020-2025)
7.3 Global Saliva-based Screening Market Size (M USD) by Application (2020-2025)
7.4 Global Saliva-based Screening Sales Growth Rate by Application (2020-2025)
8 SALIVA-BASED SCREENING MARKET SALES BY REGION
8.1 Global Saliva-based Screening Sales by Region
8.1.1 Global Saliva-based Screening Sales by Region
8.1.2 Global Saliva-based Screening Sales Market Share by Region
8.2 Global Saliva-based Screening Market Size by Region
8.2.1 Global Saliva-based Screening Market Size by Region
8.2.2 Global Saliva-based Screening Market Size by Region
8.3 North America
8.3.1 North America Saliva-based Screening Sales by Country
8.3.2 North America Saliva-based Screening Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Saliva-based Screening Sales by Country
8.4.2 Europe Saliva-based Screening Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Saliva-based Screening Sales by Region
8.5.2 Asia Pacific Saliva-based Screening Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Saliva-based Screening Sales by Country
8.6.2 South America Saliva-based Screening Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Saliva-based Screening Sales by Region
8.7.2 Middle East and Africa Saliva-based Screening Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SALIVA-BASED SCREENING MARKET PRODUCTION BY REGION
9.1 Global Production of Saliva-based Screening by Region(2020-2025)
9.2 Global Saliva-based Screening Revenue Market Share by Region (2020-2025)
9.3 Global Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Saliva-based Screening Production
9.4.1 North America Saliva-based Screening Production Growth Rate (2020-2025)
9.4.2 North America Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Saliva-based Screening Production
9.5.1 Europe Saliva-based Screening Production Growth Rate (2020-2025)
9.5.2 Europe Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Saliva-based Screening Production (2020-2025)
9.6.1 Japan Saliva-based Screening Production Growth Rate (2020-2025)
9.6.2 Japan Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Saliva-based Screening Production (2020-2025)
9.7.1 China Saliva-based Screening Production Growth Rate (2020-2025)
9.7.2 China Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Thermo Fisher scientific
10.1.1 Thermo Fisher scientific Basic Information
10.1.2 Thermo Fisher scientific Saliva-based Screening Product Overview
10.1.3 Thermo Fisher scientific Saliva-based Screening Product Market Performance
10.1.4 Thermo Fisher scientific Business Overview
10.1.5 Thermo Fisher scientific SWOT Analysis
10.1.6 Thermo Fisher scientific Recent Developments
10.2 Qiagen
10.2.1 Qiagen Basic Information
10.2.2 Qiagen Saliva-based Screening Product Overview
10.2.3 Qiagen Saliva-based Screening Product Market Performance
10.2.4 Qiagen Business Overview
10.2.5 Qiagen SWOT Analysis
10.2.6 Qiagen Recent Developments
10.3 Hologic
10.3.1 Hologic Basic Information
10.3.2 Hologic Saliva-based Screening Product Overview
10.3.3 Hologic Saliva-based Screening Product Market Performance
10.3.4 Hologic Business Overview
10.3.5 Hologic SWOT Analysis
10.3.6 Hologic Recent Developments
10.4 Takara Bio Inc
10.4.1 Takara Bio Inc Basic Information
10.4.2 Takara Bio Inc Saliva-based Screening Product Overview
10.4.3 Takara Bio Inc Saliva-based Screening Product Market Performance
10.4.4 Takara Bio Inc Business Overview
10.4.5 Takara Bio Inc Recent Developments
10.5 Arcis Biotechnology Limited
10.5.1 Arcis Biotechnology Limited Basic Information
10.5.2 Arcis Biotechnology Limited Saliva-based Screening Product Overview
10.5.3 Arcis Biotechnology Limited Saliva-based Screening Product Market Performance
10.5.4 Arcis Biotechnology Limited Business Overview
10.5.5 Arcis Biotechnology Limited Recent Developments
10.6 GeneProof
10.6.1 GeneProof Basic Information
10.6.2 GeneProof Saliva-based Screening Product Overview
10.6.3 GeneProof Saliva-based Screening Product Market Performance
10.6.4 GeneProof Business Overview
10.6.5 GeneProof Recent Developments
10.7 Abacus ALS
10.7.1 Abacus ALS Basic Information
10.7.2 Abacus ALS Saliva-based Screening Product Overview
10.7.3 Abacus ALS Saliva-based Screening Product Market Performance
10.7.4 Abacus ALS Business Overview
10.7.5 Abacus ALS Recent Developments
10.8 Chai Inc.
10.8.1 Chai Inc. Basic Information
10.8.2 Chai Inc. Saliva-based Screening Product Overview
10.8.3 Chai Inc. Saliva-based Screening Product Market Performance
10.8.4 Chai Inc. Business Overview
10.8.5 Chai Inc. Recent Developments
10.9 Kolplast Group
10.9.1 Kolplast Group Basic Information
10.9.2 Kolplast Group Saliva-based Screening Product Overview
10.9.3 Kolplast Group Saliva-based Screening Product Market Performance
10.9.4 Kolplast Group Business Overview
10.9.5 Kolplast Group Recent Developments
10.10 Lucence Health INc
10.10.1 Lucence Health INc Basic Information
10.10.2 Lucence Health INc Saliva-based Screening Product Overview
10.10.3 Lucence Health INc Saliva-based Screening Product Market Performance
10.10.4 Lucence Health INc Business Overview
10.10.5 Lucence Health INc Recent Developments
10.11 Vitagene
10.11.1 Vitagene Basic Information
10.11.2 Vitagene Saliva-based Screening Product Overview
10.11.3 Vitagene Saliva-based Screening Product Market Performance
10.11.4 Vitagene Business Overview
10.11.5 Vitagene Recent Developments
10.12 Therma Bright Inc
10.12.1 Therma Bright Inc Basic Information
10.12.2 Therma Bright Inc Saliva-based Screening Product Overview
10.12.3 Therma Bright Inc Saliva-based Screening Product Market Performance
10.12.4 Therma Bright Inc Business Overview
10.12.5 Therma Bright Inc Recent Developments
10.13 ACON Laboratories, Inc
10.13.1 ACON Laboratories, Inc Basic Information
10.13.2 ACON Laboratories, Inc Saliva-based Screening Product Overview
10.13.3 ACON Laboratories, Inc Saliva-based Screening Product Market Performance
10.13.4 ACON Laboratories, Inc Business Overview
10.13.5 ACON Laboratories, Inc Recent Developments
10.14 TODA PHARMA
10.14.1 TODA PHARMA Basic Information
10.14.2 TODA PHARMA Saliva-based Screening Product Overview
10.14.3 TODA PHARMA Saliva-based Screening Product Market Performance
10.14.4 TODA PHARMA Business Overview
10.14.5 TODA PHARMA Recent Developments
10.15 Norgen Biotek Corp.
10.15.1 Norgen Biotek Corp. Basic Information
10.15.2 Norgen Biotek Corp. Saliva-based Screening Product Overview
10.15.3 Norgen Biotek Corp. Saliva-based Screening Product Market Performance
10.15.4 Norgen Biotek Corp. Business Overview
10.15.5 Norgen Biotek Corp. Recent Developments
10.16 Assure Tech. (Hangzhou) Co., Ltd
10.16.1 Assure Tech. (Hangzhou) Co., Ltd Basic Information
10.16.2 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Overview
10.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Market Performance
10.16.4 Assure Tech. (Hangzhou) Co., Ltd Business Overview
10.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Developments
10.17 Beijing Hotgen Biotech Co., Ltd
10.17.1 Beijing Hotgen Biotech Co., Ltd Basic Information
10.17.2 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Overview
10.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Market Performance
10.17.4 Beijing Hotgen Biotech Co., Ltd Business Overview
10.17.5 Beijing Hotgen Biotech Co., Ltd Recent Developments
10.18 Nantong Diagnos Biotechnology Co., Ltd
10.18.1 Nantong Diagnos Biotechnology Co., Ltd Basic Information
10.18.2 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Overview
10.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Market Performance
10.18.4 Nantong Diagnos Biotechnology Co., Ltd Business Overview
10.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Developments
10.19 NeuMoDx Molecular, Inc.
10.19.1 NeuMoDx Molecular, Inc. Basic Information
10.19.2 NeuMoDx Molecular, Inc. Saliva-based Screening Product Overview
10.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Product Market Performance
10.19.4 NeuMoDx Molecular, Inc. Business Overview
10.19.5 NeuMoDx Molecular, Inc. Recent Developments
10.20 KYODO INTERNATIONAL INC.
10.20.1 KYODO INTERNATIONAL INC. Basic Information
10.20.2 KYODO INTERNATIONAL INC. Saliva-based Screening Product Overview
10.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Product Market Performance
10.20.4 KYODO INTERNATIONAL INC. Business Overview
10.20.5 KYODO INTERNATIONAL INC. Recent Developments
10.21 Canvax
10.21.1 Canvax Basic Information
10.21.2 Canvax Saliva-based Screening Product Overview
10.21.3 Canvax Saliva-based Screening Product Market Performance
10.21.4 Canvax Business Overview
10.21.5 Canvax Recent Developments
10.22 Zymo Research Corporation.
10.22.1 Zymo Research Corporation. Basic Information
10.22.2 Zymo Research Corporation. Saliva-based Screening Product Overview
10.22.3 Zymo Research Corporation. Saliva-based Screening Product Market Performance
10.22.4 Zymo Research Corporation. Business Overview
10.22.5 Zymo Research Corporation. Recent Developments
10.23 Salimetrics
10.23.1 Salimetrics Basic Information
10.23.2 Salimetrics Saliva-based Screening Product Overview
10.23.3 Salimetrics Saliva-based Screening Product Market Performance
10.23.4 Salimetrics Business Overview
10.23.5 Salimetrics Recent Developments
10.24 NEST Scientific USA
10.24.1 NEST Scientific USA Basic Information
10.24.2 NEST Scientific USA Saliva-based Screening Product Overview
10.24.3 NEST Scientific USA Saliva-based Screening Product Market Performance
10.24.4 NEST Scientific USA Business Overview
10.24.5 NEST Scientific USA Recent Developments
10.25 Miraclean Technology Co. Ltd
10.25.1 Miraclean Technology Co. Ltd Basic Information
10.25.2 Miraclean Technology Co. Ltd Saliva-based Screening Product Overview
10.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Product Market Performance
10.25.4 Miraclean Technology Co. Ltd Business Overview
10.25.5 Miraclean Technology Co. Ltd Recent Developments
10.26 Mawi DNA Technologies
10.26.1 Mawi DNA Technologies Basic Information
10.26.2 Mawi DNA Technologies Saliva-based Screening Product Overview
10.26.3 Mawi DNA Technologies Saliva-based Screening Product Market Performance
10.26.4 Mawi DNA Technologies Business Overview
10.26.5 Mawi DNA Technologies Recent Developments
10.27 Cell Projects Ltd.
10.27.1 Cell Projects Ltd. Basic Information
10.27.2 Cell Projects Ltd. Saliva-based Screening Product Overview
10.27.3 Cell Projects Ltd. Saliva-based Screening Product Market Performance
10.27.4 Cell Projects Ltd. Business Overview
10.27.5 Cell Projects Ltd. Recent Developments
11 SALIVA-BASED SCREENING MARKET FORECAST BY REGION
11.1 Global Saliva-based Screening Market Size Forecast
11.2 Global Saliva-based Screening Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Saliva-based Screening Market Size Forecast by Country
11.2.3 Asia Pacific Saliva-based Screening Market Size Forecast by Region
11.2.4 South America Saliva-based Screening Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Saliva-based Screening by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Saliva-based Screening Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Saliva-based Screening by Type (2026-2035)
12.1.2 Global Saliva-based Screening Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Saliva-based Screening by Type (2026-2035)
12.2 Global Saliva-based Screening Market Forecast by Application (2026-2035)
12.2.1 Global Saliva-based Screening Sales (K Units) Forecast by Application
12.2.2 Global Saliva-based Screening Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Saliva-based Screening
1.2 Key Market Segments
1.2.1 Saliva-based Screening Segment by Type
1.2.2 Saliva-based Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SALIVA-BASED SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Saliva-based Screening Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Saliva-based Screening Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SALIVA-BASED SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Saliva-based Screening Product Life Cycle
3.3 Global Saliva-based Screening Sales by Manufacturers (2020-2025)
3.4 Global Saliva-based Screening Revenue Market Share by Manufacturers (2020-2025)
3.5 Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Saliva-based Screening Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Saliva-based Screening Market Competitive Situation and Trends
3.8.1 Saliva-based Screening Market Concentration Rate
3.8.2 Global 5 and 10 Largest Saliva-based Screening Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SALIVA-BASED SCREENING INDUSTRY CHAIN ANALYSIS
4.1 Saliva-based Screening Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SALIVA-BASED SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Saliva-based Screening Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Saliva-based Screening Market
5.7 ESG Ratings of Leading Companies
6 SALIVA-BASED SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Saliva-based Screening Sales Market Share by Type (2020-2025)
6.3 Global Saliva-based Screening Market Size by Type (2020-2025)
6.4 Global Saliva-based Screening Price by Type (2020-2025)
7 SALIVA-BASED SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Saliva-based Screening Market Sales by Application (2020-2025)
7.3 Global Saliva-based Screening Market Size (M USD) by Application (2020-2025)
7.4 Global Saliva-based Screening Sales Growth Rate by Application (2020-2025)
8 SALIVA-BASED SCREENING MARKET SALES BY REGION
8.1 Global Saliva-based Screening Sales by Region
8.1.1 Global Saliva-based Screening Sales by Region
8.1.2 Global Saliva-based Screening Sales Market Share by Region
8.2 Global Saliva-based Screening Market Size by Region
8.2.1 Global Saliva-based Screening Market Size by Region
8.2.2 Global Saliva-based Screening Market Size by Region
8.3 North America
8.3.1 North America Saliva-based Screening Sales by Country
8.3.2 North America Saliva-based Screening Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Saliva-based Screening Sales by Country
8.4.2 Europe Saliva-based Screening Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Saliva-based Screening Sales by Region
8.5.2 Asia Pacific Saliva-based Screening Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Saliva-based Screening Sales by Country
8.6.2 South America Saliva-based Screening Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Saliva-based Screening Sales by Region
8.7.2 Middle East and Africa Saliva-based Screening Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SALIVA-BASED SCREENING MARKET PRODUCTION BY REGION
9.1 Global Production of Saliva-based Screening by Region(2020-2025)
9.2 Global Saliva-based Screening Revenue Market Share by Region (2020-2025)
9.3 Global Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Saliva-based Screening Production
9.4.1 North America Saliva-based Screening Production Growth Rate (2020-2025)
9.4.2 North America Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Saliva-based Screening Production
9.5.1 Europe Saliva-based Screening Production Growth Rate (2020-2025)
9.5.2 Europe Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Saliva-based Screening Production (2020-2025)
9.6.1 Japan Saliva-based Screening Production Growth Rate (2020-2025)
9.6.2 Japan Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Saliva-based Screening Production (2020-2025)
9.7.1 China Saliva-based Screening Production Growth Rate (2020-2025)
9.7.2 China Saliva-based Screening Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Thermo Fisher scientific
10.1.1 Thermo Fisher scientific Basic Information
10.1.2 Thermo Fisher scientific Saliva-based Screening Product Overview
10.1.3 Thermo Fisher scientific Saliva-based Screening Product Market Performance
10.1.4 Thermo Fisher scientific Business Overview
10.1.5 Thermo Fisher scientific SWOT Analysis
10.1.6 Thermo Fisher scientific Recent Developments
10.2 Qiagen
10.2.1 Qiagen Basic Information
10.2.2 Qiagen Saliva-based Screening Product Overview
10.2.3 Qiagen Saliva-based Screening Product Market Performance
10.2.4 Qiagen Business Overview
10.2.5 Qiagen SWOT Analysis
10.2.6 Qiagen Recent Developments
10.3 Hologic
10.3.1 Hologic Basic Information
10.3.2 Hologic Saliva-based Screening Product Overview
10.3.3 Hologic Saliva-based Screening Product Market Performance
10.3.4 Hologic Business Overview
10.3.5 Hologic SWOT Analysis
10.3.6 Hologic Recent Developments
10.4 Takara Bio Inc
10.4.1 Takara Bio Inc Basic Information
10.4.2 Takara Bio Inc Saliva-based Screening Product Overview
10.4.3 Takara Bio Inc Saliva-based Screening Product Market Performance
10.4.4 Takara Bio Inc Business Overview
10.4.5 Takara Bio Inc Recent Developments
10.5 Arcis Biotechnology Limited
10.5.1 Arcis Biotechnology Limited Basic Information
10.5.2 Arcis Biotechnology Limited Saliva-based Screening Product Overview
10.5.3 Arcis Biotechnology Limited Saliva-based Screening Product Market Performance
10.5.4 Arcis Biotechnology Limited Business Overview
10.5.5 Arcis Biotechnology Limited Recent Developments
10.6 GeneProof
10.6.1 GeneProof Basic Information
10.6.2 GeneProof Saliva-based Screening Product Overview
10.6.3 GeneProof Saliva-based Screening Product Market Performance
10.6.4 GeneProof Business Overview
10.6.5 GeneProof Recent Developments
10.7 Abacus ALS
10.7.1 Abacus ALS Basic Information
10.7.2 Abacus ALS Saliva-based Screening Product Overview
10.7.3 Abacus ALS Saliva-based Screening Product Market Performance
10.7.4 Abacus ALS Business Overview
10.7.5 Abacus ALS Recent Developments
10.8 Chai Inc.
10.8.1 Chai Inc. Basic Information
10.8.2 Chai Inc. Saliva-based Screening Product Overview
10.8.3 Chai Inc. Saliva-based Screening Product Market Performance
10.8.4 Chai Inc. Business Overview
10.8.5 Chai Inc. Recent Developments
10.9 Kolplast Group
10.9.1 Kolplast Group Basic Information
10.9.2 Kolplast Group Saliva-based Screening Product Overview
10.9.3 Kolplast Group Saliva-based Screening Product Market Performance
10.9.4 Kolplast Group Business Overview
10.9.5 Kolplast Group Recent Developments
10.10 Lucence Health INc
10.10.1 Lucence Health INc Basic Information
10.10.2 Lucence Health INc Saliva-based Screening Product Overview
10.10.3 Lucence Health INc Saliva-based Screening Product Market Performance
10.10.4 Lucence Health INc Business Overview
10.10.5 Lucence Health INc Recent Developments
10.11 Vitagene
10.11.1 Vitagene Basic Information
10.11.2 Vitagene Saliva-based Screening Product Overview
10.11.3 Vitagene Saliva-based Screening Product Market Performance
10.11.4 Vitagene Business Overview
10.11.5 Vitagene Recent Developments
10.12 Therma Bright Inc
10.12.1 Therma Bright Inc Basic Information
10.12.2 Therma Bright Inc Saliva-based Screening Product Overview
10.12.3 Therma Bright Inc Saliva-based Screening Product Market Performance
10.12.4 Therma Bright Inc Business Overview
10.12.5 Therma Bright Inc Recent Developments
10.13 ACON Laboratories, Inc
10.13.1 ACON Laboratories, Inc Basic Information
10.13.2 ACON Laboratories, Inc Saliva-based Screening Product Overview
10.13.3 ACON Laboratories, Inc Saliva-based Screening Product Market Performance
10.13.4 ACON Laboratories, Inc Business Overview
10.13.5 ACON Laboratories, Inc Recent Developments
10.14 TODA PHARMA
10.14.1 TODA PHARMA Basic Information
10.14.2 TODA PHARMA Saliva-based Screening Product Overview
10.14.3 TODA PHARMA Saliva-based Screening Product Market Performance
10.14.4 TODA PHARMA Business Overview
10.14.5 TODA PHARMA Recent Developments
10.15 Norgen Biotek Corp.
10.15.1 Norgen Biotek Corp. Basic Information
10.15.2 Norgen Biotek Corp. Saliva-based Screening Product Overview
10.15.3 Norgen Biotek Corp. Saliva-based Screening Product Market Performance
10.15.4 Norgen Biotek Corp. Business Overview
10.15.5 Norgen Biotek Corp. Recent Developments
10.16 Assure Tech. (Hangzhou) Co., Ltd
10.16.1 Assure Tech. (Hangzhou) Co., Ltd Basic Information
10.16.2 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Overview
10.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Market Performance
10.16.4 Assure Tech. (Hangzhou) Co., Ltd Business Overview
10.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Developments
10.17 Beijing Hotgen Biotech Co., Ltd
10.17.1 Beijing Hotgen Biotech Co., Ltd Basic Information
10.17.2 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Overview
10.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Market Performance
10.17.4 Beijing Hotgen Biotech Co., Ltd Business Overview
10.17.5 Beijing Hotgen Biotech Co., Ltd Recent Developments
10.18 Nantong Diagnos Biotechnology Co., Ltd
10.18.1 Nantong Diagnos Biotechnology Co., Ltd Basic Information
10.18.2 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Overview
10.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Market Performance
10.18.4 Nantong Diagnos Biotechnology Co., Ltd Business Overview
10.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Developments
10.19 NeuMoDx Molecular, Inc.
10.19.1 NeuMoDx Molecular, Inc. Basic Information
10.19.2 NeuMoDx Molecular, Inc. Saliva-based Screening Product Overview
10.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Product Market Performance
10.19.4 NeuMoDx Molecular, Inc. Business Overview
10.19.5 NeuMoDx Molecular, Inc. Recent Developments
10.20 KYODO INTERNATIONAL INC.
10.20.1 KYODO INTERNATIONAL INC. Basic Information
10.20.2 KYODO INTERNATIONAL INC. Saliva-based Screening Product Overview
10.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Product Market Performance
10.20.4 KYODO INTERNATIONAL INC. Business Overview
10.20.5 KYODO INTERNATIONAL INC. Recent Developments
10.21 Canvax
10.21.1 Canvax Basic Information
10.21.2 Canvax Saliva-based Screening Product Overview
10.21.3 Canvax Saliva-based Screening Product Market Performance
10.21.4 Canvax Business Overview
10.21.5 Canvax Recent Developments
10.22 Zymo Research Corporation.
10.22.1 Zymo Research Corporation. Basic Information
10.22.2 Zymo Research Corporation. Saliva-based Screening Product Overview
10.22.3 Zymo Research Corporation. Saliva-based Screening Product Market Performance
10.22.4 Zymo Research Corporation. Business Overview
10.22.5 Zymo Research Corporation. Recent Developments
10.23 Salimetrics
10.23.1 Salimetrics Basic Information
10.23.2 Salimetrics Saliva-based Screening Product Overview
10.23.3 Salimetrics Saliva-based Screening Product Market Performance
10.23.4 Salimetrics Business Overview
10.23.5 Salimetrics Recent Developments
10.24 NEST Scientific USA
10.24.1 NEST Scientific USA Basic Information
10.24.2 NEST Scientific USA Saliva-based Screening Product Overview
10.24.3 NEST Scientific USA Saliva-based Screening Product Market Performance
10.24.4 NEST Scientific USA Business Overview
10.24.5 NEST Scientific USA Recent Developments
10.25 Miraclean Technology Co. Ltd
10.25.1 Miraclean Technology Co. Ltd Basic Information
10.25.2 Miraclean Technology Co. Ltd Saliva-based Screening Product Overview
10.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Product Market Performance
10.25.4 Miraclean Technology Co. Ltd Business Overview
10.25.5 Miraclean Technology Co. Ltd Recent Developments
10.26 Mawi DNA Technologies
10.26.1 Mawi DNA Technologies Basic Information
10.26.2 Mawi DNA Technologies Saliva-based Screening Product Overview
10.26.3 Mawi DNA Technologies Saliva-based Screening Product Market Performance
10.26.4 Mawi DNA Technologies Business Overview
10.26.5 Mawi DNA Technologies Recent Developments
10.27 Cell Projects Ltd.
10.27.1 Cell Projects Ltd. Basic Information
10.27.2 Cell Projects Ltd. Saliva-based Screening Product Overview
10.27.3 Cell Projects Ltd. Saliva-based Screening Product Market Performance
10.27.4 Cell Projects Ltd. Business Overview
10.27.5 Cell Projects Ltd. Recent Developments
11 SALIVA-BASED SCREENING MARKET FORECAST BY REGION
11.1 Global Saliva-based Screening Market Size Forecast
11.2 Global Saliva-based Screening Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Saliva-based Screening Market Size Forecast by Country
11.2.3 Asia Pacific Saliva-based Screening Market Size Forecast by Region
11.2.4 South America Saliva-based Screening Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Saliva-based Screening by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Saliva-based Screening Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Saliva-based Screening by Type (2026-2035)
12.1.2 Global Saliva-based Screening Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Saliva-based Screening by Type (2026-2035)
12.2 Global Saliva-based Screening Market Forecast by Application (2026-2035)
12.2.1 Global Saliva-based Screening Sales (K Units) Forecast by Application
12.2.2 Global Saliva-based Screening Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Saliva-based Screening Market Size by Type (M USD)
Table 4. Global Saliva-based Screening Market Size by Application
Table 5. Saliva-based Screening Market Size Comparison by Region (M USD)
Table 6. Global Saliva-based Screening Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Saliva-based Screening Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Saliva-based Screening Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Saliva-based Screening Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2025)
Table 11. Global Market Saliva-based Screening Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Saliva-based Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Saliva-based Screening Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Saliva-based Screening Sales by Type (K Units)
Table 27. Global Saliva-based Screening Market Size by Type (M USD)
Table 28. Global Saliva-based Screening Sales (K Units) by Type (2020-2025)
Table 29. Global Saliva-based Screening Sales Market Share by Type (2020-2025)
Table 30. Global Saliva-based Screening Market Size (M USD) by Type (2020-2025)
Table 31. Global Saliva-based Screening Market Share by Type (2020-2025)
Table 32. Global Saliva-based Screening Price (USD/Unit) by Type (2020-2025)
Table 33. Global Saliva-based Screening Sales (K Units) by Application
Table 34. Global Saliva-based Screening Market Size by Application
Table 35. Global Saliva-based Screening Sales by Application (2020-2025) & (K Units)
Table 36. Global Saliva-based Screening Sales Market Share by Application (2020-2025)
Table 37. Global Saliva-based Screening Market Size by Application (2020-2025) & (M USD)
Table 38. Global Saliva-based Screening Market Share by Application (2020-2025)
Table 39. Global Saliva-based Screening Sales Growth Rate by Application (2020-2025)
Table 40. Global Saliva-based Screening Sales by Region (2020-2025) & (K Units)
Table 41. Global Saliva-based Screening Sales Market Share by Region (2020-2025)
Table 42. Global Saliva-based Screening Market Size by Region (2020-2025) & (M USD)
Table 43. Global Saliva-based Screening Market Size by Region (2020-2025)
Table 44. North America Saliva-based Screening Sales by Country (2020-2025) & (K Units)
Table 45. North America Saliva-based Screening Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Saliva-based Screening Sales by Country (2020-2025) & (K Units)
Table 47. Europe Saliva-based Screening Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Saliva-based Screening Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Saliva-based Screening Market Size by Region (2020-2025) & (M USD)
Table 50. South America Saliva-based Screening Sales by Country (2020-2025) & (K Units)
Table 51. South America Saliva-based Screening Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Saliva-based Screening Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Saliva-based Screening Market Size by Region (2020-2025) & (M USD)
Table 54. Global Saliva-based Screening Production (K Units) by Region(2020-2025)
Table 55. Global Saliva-based Screening Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Saliva-based Screening Revenue Market Share by Region (2020-2025)
Table 57. Global Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Thermo Fisher scientific Basic Information
Table 63. Thermo Fisher scientific Saliva-based Screening Product Overview
Table 64. Thermo Fisher scientific Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Thermo Fisher scientific Business Overview
Table 66. Thermo Fisher scientific SWOT Analysis
Table 67. Thermo Fisher scientific Recent Developments
Table 68. Qiagen Basic Information
Table 69. Qiagen Saliva-based Screening Product Overview
Table 70. Qiagen Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Qiagen Business Overview
Table 72. Qiagen SWOT Analysis
Table 73. Qiagen Recent Developments
Table 74. Hologic Basic Information
Table 75. Hologic Saliva-based Screening Product Overview
Table 76. Hologic Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Hologic Business Overview
Table 78. Hologic SWOT Analysis
Table 79. Hologic Recent Developments
Table 80. Takara Bio Inc Basic Information
Table 81. Takara Bio Inc Saliva-based Screening Product Overview
Table 82. Takara Bio Inc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Takara Bio Inc Business Overview
Table 84. Takara Bio Inc Recent Developments
Table 85. Arcis Biotechnology Limited Basic Information
Table 86. Arcis Biotechnology Limited Saliva-based Screening Product Overview
Table 87. Arcis Biotechnology Limited Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Arcis Biotechnology Limited Business Overview
Table 89. Arcis Biotechnology Limited Recent Developments
Table 90. GeneProof Basic Information
Table 91. GeneProof Saliva-based Screening Product Overview
Table 92. GeneProof Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GeneProof Business Overview
Table 94. GeneProof Recent Developments
Table 95. Abacus ALS Basic Information
Table 96. Abacus ALS Saliva-based Screening Product Overview
Table 97. Abacus ALS Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Abacus ALS Business Overview
Table 99. Abacus ALS Recent Developments
Table 100. Chai Inc. Basic Information
Table 101. Chai Inc. Saliva-based Screening Product Overview
Table 102. Chai Inc. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Chai Inc. Business Overview
Table 104. Chai Inc. Recent Developments
Table 105. Kolplast Group Basic Information
Table 106. Kolplast Group Saliva-based Screening Product Overview
Table 107. Kolplast Group Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Kolplast Group Business Overview
Table 109. Kolplast Group Recent Developments
Table 110. Lucence Health INc Basic Information
Table 111. Lucence Health INc Saliva-based Screening Product Overview
Table 112. Lucence Health INc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Lucence Health INc Business Overview
Table 114. Lucence Health INc Recent Developments
Table 115. Vitagene Basic Information
Table 116. Vitagene Saliva-based Screening Product Overview
Table 117. Vitagene Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Vitagene Business Overview
Table 119. Vitagene Recent Developments
Table 120. Therma Bright Inc Basic Information
Table 121. Therma Bright Inc Saliva-based Screening Product Overview
Table 122. Therma Bright Inc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Therma Bright Inc Business Overview
Table 124. Therma Bright Inc Recent Developments
Table 125. ACON Laboratories, Inc Basic Information
Table 126. ACON Laboratories, Inc Saliva-based Screening Product Overview
Table 127. ACON Laboratories, Inc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. ACON Laboratories, Inc Business Overview
Table 129. ACON Laboratories, Inc Recent Developments
Table 130. TODA PHARMA Basic Information
Table 131. TODA PHARMA Saliva-based Screening Product Overview
Table 132. TODA PHARMA Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. TODA PHARMA Business Overview
Table 134. TODA PHARMA Recent Developments
Table 135. Norgen Biotek Corp. Basic Information
Table 136. Norgen Biotek Corp. Saliva-based Screening Product Overview
Table 137. Norgen Biotek Corp. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Norgen Biotek Corp. Business Overview
Table 139. Norgen Biotek Corp. Recent Developments
Table 140. Assure Tech. (Hangzhou) Co., Ltd Basic Information
Table 141. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Overview
Table 142. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Assure Tech. (Hangzhou) Co., Ltd Business Overview
Table 144. Assure Tech. (Hangzhou) Co., Ltd Recent Developments
Table 145. Beijing Hotgen Biotech Co., Ltd Basic Information
Table 146. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Overview
Table 147. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Beijing Hotgen Biotech Co., Ltd Business Overview
Table 149. Beijing Hotgen Biotech Co., Ltd Recent Developments
Table 150. Nantong Diagnos Biotechnology Co., Ltd Basic Information
Table 151. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Overview
Table 152. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Nantong Diagnos Biotechnology Co., Ltd Business Overview
Table 154. Nantong Diagnos Biotechnology Co., Ltd Recent Developments
Table 155. NeuMoDx Molecular, Inc. Basic Information
Table 156. NeuMoDx Molecular, Inc. Saliva-based Screening Product Overview
Table 157. NeuMoDx Molecular, Inc. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. NeuMoDx Molecular, Inc. Business Overview
Table 159. NeuMoDx Molecular, Inc. Recent Developments
Table 160. KYODO INTERNATIONAL INC. Basic Information
Table 161. KYODO INTERNATIONAL INC. Saliva-based Screening Product Overview
Table 162. KYODO INTERNATIONAL INC. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. KYODO INTERNATIONAL INC. Business Overview
Table 164. KYODO INTERNATIONAL INC. Recent Developments
Table 165. Canvax Basic Information
Table 166. Canvax Saliva-based Screening Product Overview
Table 167. Canvax Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Canvax Business Overview
Table 169. Canvax Recent Developments
Table 170. Zymo Research Corporation. Basic Information
Table 171. Zymo Research Corporation. Saliva-based Screening Product Overview
Table 172. Zymo Research Corporation. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Zymo Research Corporation. Business Overview
Table 174. Zymo Research Corporation. Recent Developments
Table 175. Salimetrics Basic Information
Table 176. Salimetrics Saliva-based Screening Product Overview
Table 177. Salimetrics Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Salimetrics Business Overview
Table 179. Salimetrics Recent Developments
Table 180. NEST Scientific USA Basic Information
Table 181. NEST Scientific USA Saliva-based Screening Product Overview
Table 182. NEST Scientific USA Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. NEST Scientific USA Business Overview
Table 184. NEST Scientific USA Recent Developments
Table 185. Miraclean Technology Co. Ltd Basic Information
Table 186. Miraclean Technology Co. Ltd Saliva-based Screening Product Overview
Table 187. Miraclean Technology Co. Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Miraclean Technology Co. Ltd Business Overview
Table 189. Miraclean Technology Co. Ltd Recent Developments
Table 190. Mawi DNA Technologies Basic Information
Table 191. Mawi DNA Technologies Saliva-based Screening Product Overview
Table 192. Mawi DNA Technologies Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Mawi DNA Technologies Business Overview
Table 194. Mawi DNA Technologies Recent Developments
Table 195. Cell Projects Ltd. Basic Information
Table 196. Cell Projects Ltd. Saliva-based Screening Product Overview
Table 197. Cell Projects Ltd. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. Cell Projects Ltd. Business Overview
Table 199. Cell Projects Ltd. Recent Developments
Table 200. Global Saliva-based Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 201. Global Saliva-based Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 202. North America Saliva-based Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 203. North America Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 204. Europe Saliva-based Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 205. Europe Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 206. Asia Pacific Saliva-based Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 207. Asia Pacific Saliva-based Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 208. South America Saliva-based Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 209. South America Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 210. Middle East and Africa Saliva-based Screening Sales Forecast by Country (2026-2035) & (Units)
Table 211. Middle East and Africa Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 212. Global Saliva-based Screening Sales Forecast by Type (2026-2035) & (K Units)
Table 213. Global Saliva-based Screening Market Size Forecast by Type (2026-2035) & (M USD)
Table 214. Global Saliva-based Screening Price Forecast by Type (2026-2035) & (USD/Unit)
Table 215. Global Saliva-based Screening Sales (K Units) Forecast by Application (2026-2035)
Table 216. Global Saliva-based Screening Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Saliva-based Screening Market Size by Type (M USD)
Table 4. Global Saliva-based Screening Market Size by Application
Table 5. Saliva-based Screening Market Size Comparison by Region (M USD)
Table 6. Global Saliva-based Screening Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Saliva-based Screening Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Saliva-based Screening Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Saliva-based Screening Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2025)
Table 11. Global Market Saliva-based Screening Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Saliva-based Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Saliva-based Screening Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Saliva-based Screening Sales by Type (K Units)
Table 27. Global Saliva-based Screening Market Size by Type (M USD)
Table 28. Global Saliva-based Screening Sales (K Units) by Type (2020-2025)
Table 29. Global Saliva-based Screening Sales Market Share by Type (2020-2025)
Table 30. Global Saliva-based Screening Market Size (M USD) by Type (2020-2025)
Table 31. Global Saliva-based Screening Market Share by Type (2020-2025)
Table 32. Global Saliva-based Screening Price (USD/Unit) by Type (2020-2025)
Table 33. Global Saliva-based Screening Sales (K Units) by Application
Table 34. Global Saliva-based Screening Market Size by Application
Table 35. Global Saliva-based Screening Sales by Application (2020-2025) & (K Units)
Table 36. Global Saliva-based Screening Sales Market Share by Application (2020-2025)
Table 37. Global Saliva-based Screening Market Size by Application (2020-2025) & (M USD)
Table 38. Global Saliva-based Screening Market Share by Application (2020-2025)
Table 39. Global Saliva-based Screening Sales Growth Rate by Application (2020-2025)
Table 40. Global Saliva-based Screening Sales by Region (2020-2025) & (K Units)
Table 41. Global Saliva-based Screening Sales Market Share by Region (2020-2025)
Table 42. Global Saliva-based Screening Market Size by Region (2020-2025) & (M USD)
Table 43. Global Saliva-based Screening Market Size by Region (2020-2025)
Table 44. North America Saliva-based Screening Sales by Country (2020-2025) & (K Units)
Table 45. North America Saliva-based Screening Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Saliva-based Screening Sales by Country (2020-2025) & (K Units)
Table 47. Europe Saliva-based Screening Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Saliva-based Screening Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Saliva-based Screening Market Size by Region (2020-2025) & (M USD)
Table 50. South America Saliva-based Screening Sales by Country (2020-2025) & (K Units)
Table 51. South America Saliva-based Screening Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Saliva-based Screening Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Saliva-based Screening Market Size by Region (2020-2025) & (M USD)
Table 54. Global Saliva-based Screening Production (K Units) by Region(2020-2025)
Table 55. Global Saliva-based Screening Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Saliva-based Screening Revenue Market Share by Region (2020-2025)
Table 57. Global Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Saliva-based Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Thermo Fisher scientific Basic Information
Table 63. Thermo Fisher scientific Saliva-based Screening Product Overview
Table 64. Thermo Fisher scientific Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Thermo Fisher scientific Business Overview
Table 66. Thermo Fisher scientific SWOT Analysis
Table 67. Thermo Fisher scientific Recent Developments
Table 68. Qiagen Basic Information
Table 69. Qiagen Saliva-based Screening Product Overview
Table 70. Qiagen Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Qiagen Business Overview
Table 72. Qiagen SWOT Analysis
Table 73. Qiagen Recent Developments
Table 74. Hologic Basic Information
Table 75. Hologic Saliva-based Screening Product Overview
Table 76. Hologic Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Hologic Business Overview
Table 78. Hologic SWOT Analysis
Table 79. Hologic Recent Developments
Table 80. Takara Bio Inc Basic Information
Table 81. Takara Bio Inc Saliva-based Screening Product Overview
Table 82. Takara Bio Inc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Takara Bio Inc Business Overview
Table 84. Takara Bio Inc Recent Developments
Table 85. Arcis Biotechnology Limited Basic Information
Table 86. Arcis Biotechnology Limited Saliva-based Screening Product Overview
Table 87. Arcis Biotechnology Limited Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Arcis Biotechnology Limited Business Overview
Table 89. Arcis Biotechnology Limited Recent Developments
Table 90. GeneProof Basic Information
Table 91. GeneProof Saliva-based Screening Product Overview
Table 92. GeneProof Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GeneProof Business Overview
Table 94. GeneProof Recent Developments
Table 95. Abacus ALS Basic Information
Table 96. Abacus ALS Saliva-based Screening Product Overview
Table 97. Abacus ALS Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Abacus ALS Business Overview
Table 99. Abacus ALS Recent Developments
Table 100. Chai Inc. Basic Information
Table 101. Chai Inc. Saliva-based Screening Product Overview
Table 102. Chai Inc. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Chai Inc. Business Overview
Table 104. Chai Inc. Recent Developments
Table 105. Kolplast Group Basic Information
Table 106. Kolplast Group Saliva-based Screening Product Overview
Table 107. Kolplast Group Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Kolplast Group Business Overview
Table 109. Kolplast Group Recent Developments
Table 110. Lucence Health INc Basic Information
Table 111. Lucence Health INc Saliva-based Screening Product Overview
Table 112. Lucence Health INc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Lucence Health INc Business Overview
Table 114. Lucence Health INc Recent Developments
Table 115. Vitagene Basic Information
Table 116. Vitagene Saliva-based Screening Product Overview
Table 117. Vitagene Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Vitagene Business Overview
Table 119. Vitagene Recent Developments
Table 120. Therma Bright Inc Basic Information
Table 121. Therma Bright Inc Saliva-based Screening Product Overview
Table 122. Therma Bright Inc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Therma Bright Inc Business Overview
Table 124. Therma Bright Inc Recent Developments
Table 125. ACON Laboratories, Inc Basic Information
Table 126. ACON Laboratories, Inc Saliva-based Screening Product Overview
Table 127. ACON Laboratories, Inc Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. ACON Laboratories, Inc Business Overview
Table 129. ACON Laboratories, Inc Recent Developments
Table 130. TODA PHARMA Basic Information
Table 131. TODA PHARMA Saliva-based Screening Product Overview
Table 132. TODA PHARMA Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. TODA PHARMA Business Overview
Table 134. TODA PHARMA Recent Developments
Table 135. Norgen Biotek Corp. Basic Information
Table 136. Norgen Biotek Corp. Saliva-based Screening Product Overview
Table 137. Norgen Biotek Corp. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Norgen Biotek Corp. Business Overview
Table 139. Norgen Biotek Corp. Recent Developments
Table 140. Assure Tech. (Hangzhou) Co., Ltd Basic Information
Table 141. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Overview
Table 142. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Assure Tech. (Hangzhou) Co., Ltd Business Overview
Table 144. Assure Tech. (Hangzhou) Co., Ltd Recent Developments
Table 145. Beijing Hotgen Biotech Co., Ltd Basic Information
Table 146. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Overview
Table 147. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Beijing Hotgen Biotech Co., Ltd Business Overview
Table 149. Beijing Hotgen Biotech Co., Ltd Recent Developments
Table 150. Nantong Diagnos Biotechnology Co., Ltd Basic Information
Table 151. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Overview
Table 152. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Nantong Diagnos Biotechnology Co., Ltd Business Overview
Table 154. Nantong Diagnos Biotechnology Co., Ltd Recent Developments
Table 155. NeuMoDx Molecular, Inc. Basic Information
Table 156. NeuMoDx Molecular, Inc. Saliva-based Screening Product Overview
Table 157. NeuMoDx Molecular, Inc. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. NeuMoDx Molecular, Inc. Business Overview
Table 159. NeuMoDx Molecular, Inc. Recent Developments
Table 160. KYODO INTERNATIONAL INC. Basic Information
Table 161. KYODO INTERNATIONAL INC. Saliva-based Screening Product Overview
Table 162. KYODO INTERNATIONAL INC. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. KYODO INTERNATIONAL INC. Business Overview
Table 164. KYODO INTERNATIONAL INC. Recent Developments
Table 165. Canvax Basic Information
Table 166. Canvax Saliva-based Screening Product Overview
Table 167. Canvax Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Canvax Business Overview
Table 169. Canvax Recent Developments
Table 170. Zymo Research Corporation. Basic Information
Table 171. Zymo Research Corporation. Saliva-based Screening Product Overview
Table 172. Zymo Research Corporation. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Zymo Research Corporation. Business Overview
Table 174. Zymo Research Corporation. Recent Developments
Table 175. Salimetrics Basic Information
Table 176. Salimetrics Saliva-based Screening Product Overview
Table 177. Salimetrics Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Salimetrics Business Overview
Table 179. Salimetrics Recent Developments
Table 180. NEST Scientific USA Basic Information
Table 181. NEST Scientific USA Saliva-based Screening Product Overview
Table 182. NEST Scientific USA Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. NEST Scientific USA Business Overview
Table 184. NEST Scientific USA Recent Developments
Table 185. Miraclean Technology Co. Ltd Basic Information
Table 186. Miraclean Technology Co. Ltd Saliva-based Screening Product Overview
Table 187. Miraclean Technology Co. Ltd Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Miraclean Technology Co. Ltd Business Overview
Table 189. Miraclean Technology Co. Ltd Recent Developments
Table 190. Mawi DNA Technologies Basic Information
Table 191. Mawi DNA Technologies Saliva-based Screening Product Overview
Table 192. Mawi DNA Technologies Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Mawi DNA Technologies Business Overview
Table 194. Mawi DNA Technologies Recent Developments
Table 195. Cell Projects Ltd. Basic Information
Table 196. Cell Projects Ltd. Saliva-based Screening Product Overview
Table 197. Cell Projects Ltd. Saliva-based Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. Cell Projects Ltd. Business Overview
Table 199. Cell Projects Ltd. Recent Developments
Table 200. Global Saliva-based Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 201. Global Saliva-based Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 202. North America Saliva-based Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 203. North America Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 204. Europe Saliva-based Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 205. Europe Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 206. Asia Pacific Saliva-based Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 207. Asia Pacific Saliva-based Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 208. South America Saliva-based Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 209. South America Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 210. Middle East and Africa Saliva-based Screening Sales Forecast by Country (2026-2035) & (Units)
Table 211. Middle East and Africa Saliva-based Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 212. Global Saliva-based Screening Sales Forecast by Type (2026-2035) & (K Units)
Table 213. Global Saliva-based Screening Market Size Forecast by Type (2026-2035) & (M USD)
Table 214. Global Saliva-based Screening Price Forecast by Type (2026-2035) & (USD/Unit)
Table 215. Global Saliva-based Screening Sales (K Units) Forecast by Application (2026-2035)
Table 216. Global Saliva-based Screening Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Saliva-based Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Saliva-based Screening Market Size (M USD), 2025-2035
Figure 5. Global Saliva-based Screening Market Size (M USD) (2020-2035)
Figure 6. Global Saliva-based Screening Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Saliva-based Screening Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Saliva-based Screening Product Life Cycle
Figure 13. Saliva-based Screening Sales Share by Manufacturers in 2025
Figure 14. Global Saliva-based Screening Revenue Share by Manufacturers in 2025
Figure 15. Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Saliva-based Screening Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Saliva-based Screening Revenue in 2025
Figure 18. Industry Chain Map of Saliva-based Screening
Figure 19. Global Saliva-based Screening Market PEST Analysis
Figure 20. Global Saliva-based Screening Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Saliva-based Screening Market Share by Type
Figure 27. Sales Market Share of Saliva-based Screening by Type (2020-2025)
Figure 28. Sales Market Share of Saliva-based Screening by Type in 2025
Figure 29. Market Share of Saliva-based Screening by Type (2020-2025)
Figure 30. Market Share of Saliva-based Screening by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Saliva-based Screening Market Share by Application
Figure 33. Global Saliva-based Screening Sales Market Share by Application (2020-2025)
Figure 34. Global Saliva-based Screening Sales Market Share by Application in 2025
Figure 35. Global Saliva-based Screening Market Share by Application (2020-2025)
Figure 36. Global Saliva-based Screening Market Share by Application in 2025
Figure 37. Global Saliva-based Screening Sales Growth Rate by Application (2020-2025)
Figure 38. Global Saliva-based Screening Sales Market Share by Region (2020-2025)
Figure 39. Global Saliva-based Screening Market Size by Region (2020-2025)
Figure 40. North America Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Saliva-based Screening Sales Market Share by Country in 2024
Figure 43. North America Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Saliva-based Screening Market Size by Country in 2024
Figure 45. U.S. Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Saliva-based Screening Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Saliva-based Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Saliva-based Screening Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Saliva-based Screening Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Saliva-based Screening Sales Market Share by Country in 2024
Figure 53. Europe Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Saliva-based Screening Market Size by Country in 2024
Figure 55. Germany Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Saliva-based Screening Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Saliva-based Screening Sales Market Share by Region in 2024
Figure 67. Asia Pacific Saliva-based Screening Market Size by Region in 2024
Figure 68. China Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Saliva-based Screening Sales and Growth Rate (K Units)
Figure 79. South America Saliva-based Screening Sales Market Share by Country in 2024
Figure 80. South America Saliva-based Screening Market Size and Growth Rate (M USD)
Figure 81. South America Saliva-based Screening Market Size by Country in 2024
Figure 82. Brazil Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Saliva-based Screening Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Saliva-based Screening Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Saliva-based Screening Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Saliva-based Screening Market Size by Region in 2024
Figure 92. Saudi Arabia Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Saliva-based Screening Production Market Share by Region (2020-2025)
Figure 103. North America Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 106. China Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Saliva-based Screening Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Saliva-based Screening Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Saliva-based Screening Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Saliva-based Screening Market Share Forecast by Type (2026-2035)
Figure 111. Global Saliva-based Screening Sales Forecast by Application (2026-2035)
Figure 112. Global Saliva-based Screening Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Saliva-based Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Saliva-based Screening Market Size (M USD), 2025-2035
Figure 5. Global Saliva-based Screening Market Size (M USD) (2020-2035)
Figure 6. Global Saliva-based Screening Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Saliva-based Screening Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Saliva-based Screening Product Life Cycle
Figure 13. Saliva-based Screening Sales Share by Manufacturers in 2025
Figure 14. Global Saliva-based Screening Revenue Share by Manufacturers in 2025
Figure 15. Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Saliva-based Screening Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Saliva-based Screening Revenue in 2025
Figure 18. Industry Chain Map of Saliva-based Screening
Figure 19. Global Saliva-based Screening Market PEST Analysis
Figure 20. Global Saliva-based Screening Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Saliva-based Screening Market Share by Type
Figure 27. Sales Market Share of Saliva-based Screening by Type (2020-2025)
Figure 28. Sales Market Share of Saliva-based Screening by Type in 2025
Figure 29. Market Share of Saliva-based Screening by Type (2020-2025)
Figure 30. Market Share of Saliva-based Screening by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Saliva-based Screening Market Share by Application
Figure 33. Global Saliva-based Screening Sales Market Share by Application (2020-2025)
Figure 34. Global Saliva-based Screening Sales Market Share by Application in 2025
Figure 35. Global Saliva-based Screening Market Share by Application (2020-2025)
Figure 36. Global Saliva-based Screening Market Share by Application in 2025
Figure 37. Global Saliva-based Screening Sales Growth Rate by Application (2020-2025)
Figure 38. Global Saliva-based Screening Sales Market Share by Region (2020-2025)
Figure 39. Global Saliva-based Screening Market Size by Region (2020-2025)
Figure 40. North America Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Saliva-based Screening Sales Market Share by Country in 2024
Figure 43. North America Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Saliva-based Screening Market Size by Country in 2024
Figure 45. U.S. Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Saliva-based Screening Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Saliva-based Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Saliva-based Screening Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Saliva-based Screening Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Saliva-based Screening Sales Market Share by Country in 2024
Figure 53. Europe Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Saliva-based Screening Market Size by Country in 2024
Figure 55. Germany Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Saliva-based Screening Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Saliva-based Screening Sales Market Share by Region in 2024
Figure 67. Asia Pacific Saliva-based Screening Market Size by Region in 2024
Figure 68. China Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Saliva-based Screening Sales and Growth Rate (K Units)
Figure 79. South America Saliva-based Screening Sales Market Share by Country in 2024
Figure 80. South America Saliva-based Screening Market Size and Growth Rate (M USD)
Figure 81. South America Saliva-based Screening Market Size by Country in 2024
Figure 82. Brazil Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Saliva-based Screening Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Saliva-based Screening Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Saliva-based Screening Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Saliva-based Screening Market Size by Region in 2024
Figure 92. Saudi Arabia Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Saliva-based Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Saliva-based Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Saliva-based Screening Production Market Share by Region (2020-2025)
Figure 103. North America Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 106. China Saliva-based Screening Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Saliva-based Screening Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Saliva-based Screening Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Saliva-based Screening Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Saliva-based Screening Market Share Forecast by Type (2026-2035)
Figure 111. Global Saliva-based Screening Sales Forecast by Application (2026-2035)
Figure 112. Global Saliva-based Screening Market Share Forecast by Application (2026-2035)
